The Supplier Relationship Pivot
5 of 6 filers across 2 sectors are noting supply conditions. Accelerated into 2025Q4, since cooling. Direction flipped — 2025Q4 was 40% falling; 2026Q1 now 75% neutral. Mixed: supply (45%), risk (27%), strategic (27%). Present-tense — companies describing what is happening now. Recent filings describe "engage with suppliers to proactively manage potential disruptions, critical material constraints, and pricing volatility."
Companies are actively managing supplier concentration and geographic risk through strategic relationship-building and dual-sourcing practices, shifting from passive exposure to proactive supply-chain resilience.
DISTINCT NEW FILERS PER QUARTER
✦ WHAT THE DIFF CAUGHT
Risk language (LLY, AVGO, DE) contrasts with forward-looking mitigation and partnership strengthening (HON, HD), signaling a shift from acknowledging vulnerability to claiming competitive advantage through supplier collaboration.
REPRESENTATIVE SIGNAL FROM FILINGS
“engage with suppliers to proactively manage potential disruptions, critical material constraints, and pricing volatility”
The company is proactively engaging with suppliers to manage potential disruptions, critical material constraints, and pricing volatility.
“pharmaceutical industry generally, depend on China-based suppliers for portions of our supply chain”
The company and the broader pharmaceutical industry depend on China-based suppliers for portions of the supply chain.
DRIVERS